Securities code: 688553 securities abbreviation: Sichuan Huiyu Pharmaceutical Co.Ltd(688553) Announcement No.: 2022-002 Sichuan Huiyu Pharmaceutical Co.Ltd(688553)
Announcement of resolutions of the board of supervisors
The board of supervisors and all supervisors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
1、 Meetings of the board of supervisors
Sichuan Huiyu Pharmaceutical Co.Ltd(688553) (hereinafter referred to as “the company”), the 12th meeting of the first board of supervisors was notified by e-mail on January 6, 2022 and held in the company’s conference room by on-site combined communication on January 11, 2022. The meeting was convened and presided over by Ms. Liang Duohui, chairman of the board of supervisors of the company. There were 6 supervisors who should attend and 6 supervisors who actually attended. All supervisors approved the notice time, proposal content and other matters of the meeting. The convening and convening procedures of the board of supervisors met the company law of the people’s Republic of China, the securities law of the people’s Republic of China and other laws and regulations and the relevant provisions of the Sichuan Huiyu Pharmaceutical Co.Ltd(688553) articles of association, and the resolutions of the meeting were legal and effective.
2、 Deliberation at the meeting of the board of supervisors
(I) deliberated and passed the proposal on using some over raised funds to invest in new projects. Voting results: 6 votes in favor; 0 abstentions; 0 votes against.
For details of this proposal, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) published by the company on the same day Announcement on Sichuan Huiyu Pharmaceutical Co.Ltd(688553) using part of the over raised funds to invest in the construction of new projects (Announcement No.: 2022-003).
(II) deliberated and passed the proposal on foreign investment in private equity funds and related party transactions by wholly-owned subsidiaries
Voting results: 5 votes in favor; 0 abstentions; 0 votes against.
Wang Shuguang, a related supervisor, avoided voting.
For details of this proposal, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) published by the company on the same day Announcement on foreign investment in private equity funds and related party transactions by wholly-owned subsidiaries (Announcement No.: 2022-004). (III) deliberated and passed the proposal on the expected daily connected transactions of the company in 2022. Voting results: 6 votes in favor; 0 abstentions; 0 votes against.
For details of this proposal, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) published by the company on the same day Announcement of Sichuan Huiyu Pharmaceutical Co.Ltd(688553) on the expected daily connected transactions of the company in 2022 (Announcement No.: 2022-005). 3、 Document for future reference (I) Sichuan Huiyu Pharmaceutical Co.Ltd(688553) resolution of the 12th meeting of the first board of supervisors.
It is hereby announced.
Sichuan Huiyu Pharmaceutical Co.Ltd(688553) board of supervisors January 12, 2022
